Levosulpiride associated neuroleptic malignant syndrome in an elderly patient: a tale of confusing brand names
- 20 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Acta Neurologica Belgica
- Vol. 122 (4), 1103-1105
- https://doi.org/10.1007/s13760-021-01627-z
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2019
- L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza’s syndromeNeurological Sciences, 2018
- A Prospective Observational Pilot Study of Adverse Drug Reactions in Patients Admitted in the Geriatric Ward of a Tertiary Hospital in North IndiaCurrent Pharmacogenomics and Personalized Medicine, 2018
- Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritisBMJ Case Reports, 2018
- A rare case of neuroleptic malignant syndrome without elevated serum creatine kinaseNeuropsychiatric Disease and Treatment, 2014
- Neuroleptic Malignant SyndromeThe Neurohospitalist, 2011
- Rational prescribing: the principles of drug selectionClinical Medicine, 2009
- Medication errors: prescribing faults and prescription errorsBritish Journal of Clinical Pharmacology, 2009